vs

Side-by-side financial comparison of Harmony Biosciences Holdings, Inc. (HRMY) and MediaAlpha, Inc. (MAX). Click either name above to swap in a different company.

MediaAlpha, Inc. is the larger business by last-quarter revenue ($310.0M vs $243.8M, roughly 1.3× Harmony Biosciences Holdings, Inc.). Harmony Biosciences Holdings, Inc. runs the higher net margin — 9.2% vs 4.5%, a 4.7% gap on every dollar of revenue. On growth, Harmony Biosciences Holdings, Inc. posted the faster year-over-year revenue change (21.1% vs 17.3%). Over the past eight quarters, MediaAlpha, Inc.'s revenue compounded faster (31.9% CAGR vs 25.6%).

Harmony Biosciences Holdings, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for rare neurological and central nervous system disorders. Its primary market is the United States, with its core product serving patients living with narcolepsy and other sleep-related CNS conditions across adult and pediatric segments.

Alpha Group Co., Ltd. is a Chinese multinational conglomerate with animation, toy, mass media asset and entertainment company headquartered created by Cai Dongqing in 1993. In 2016, it changed its name from Alpha Animation. The company has a Chinese webcomics site, U17, and also an American film company, Alpha Pictures, and has announced the creation of an animation division also based in the United States.

HRMY vs MAX — Head-to-Head

Bigger by revenue
MAX
MAX
1.3× larger
MAX
$310.0M
$243.8M
HRMY
Growing faster (revenue YoY)
HRMY
HRMY
+3.8% gap
HRMY
21.1%
17.3%
MAX
Higher net margin
HRMY
HRMY
4.7% more per $
HRMY
9.2%
4.5%
MAX
Faster 2-yr revenue CAGR
MAX
MAX
Annualised
MAX
31.9%
25.6%
HRMY

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
HRMY
HRMY
MAX
MAX
Revenue
$243.8M
$310.0M
Net Profit
$22.5M
$14.0M
Gross Margin
71.9%
15.1%
Operating Margin
15.8%
7.2%
Net Margin
9.2%
4.5%
Revenue YoY
21.1%
17.3%
Net Profit YoY
-54.6%
701.8%
EPS (diluted)
$0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HRMY
HRMY
MAX
MAX
Q1 26
$310.0M
Q4 25
$243.8M
$291.2M
Q3 25
$239.5M
$306.5M
Q2 25
$200.5M
$251.6M
Q1 25
$184.7M
$264.3M
Q4 24
$201.3M
$300.6M
Q3 24
$186.0M
$259.1M
Q2 24
$172.8M
$178.3M
Net Profit
HRMY
HRMY
MAX
MAX
Q1 26
$14.0M
Q4 25
$22.5M
$31.4M
Q3 25
$50.9M
$14.9M
Q2 25
$39.8M
$-18.7M
Q1 25
$45.6M
$-1.9M
Q4 24
$49.5M
$4.6M
Q3 24
$46.1M
$9.5M
Q2 24
$11.6M
$3.6M
Gross Margin
HRMY
HRMY
MAX
MAX
Q1 26
15.1%
Q4 25
71.9%
15.4%
Q3 25
75.1%
14.2%
Q2 25
81.0%
15.0%
Q1 25
82.7%
15.8%
Q4 24
73.0%
16.3%
Q3 24
77.0%
15.1%
Q2 24
81.4%
17.8%
Operating Margin
HRMY
HRMY
MAX
MAX
Q1 26
7.2%
Q4 25
15.8%
7.7%
Q3 25
27.3%
6.4%
Q2 25
24.0%
-8.0%
Q1 25
30.4%
0.0%
Q4 24
27.7%
6.1%
Q3 24
33.2%
6.0%
Q2 24
12.4%
3.6%
Net Margin
HRMY
HRMY
MAX
MAX
Q1 26
4.5%
Q4 25
9.2%
10.8%
Q3 25
21.2%
4.9%
Q2 25
19.8%
-7.4%
Q1 25
24.7%
-0.7%
Q4 24
24.6%
1.5%
Q3 24
24.8%
3.7%
Q2 24
6.7%
2.0%
EPS (diluted)
HRMY
HRMY
MAX
MAX
Q1 26
Q4 25
$0.38
$0.50
Q3 25
$0.87
$0.26
Q2 25
$0.68
$-0.33
Q1 25
$0.78
$-0.04
Q4 24
$0.85
$0.09
Q3 24
$0.79
$0.17
Q2 24
$0.20
$0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HRMY
HRMY
MAX
MAX
Cash + ST InvestmentsLiquidity on hand
$775.3M
$26.1M
Total DebtLower is stronger
$163.7M
$163.5M
Stockholders' EquityBook value
$870.2M
Total Assets
$1.3B
$367.7M
Debt / EquityLower = less leverage
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HRMY
HRMY
MAX
MAX
Q1 26
$26.1M
Q4 25
$775.3M
$46.9M
Q3 25
$672.6M
$38.8M
Q2 25
$565.3M
$85.4M
Q1 25
$507.0M
$63.6M
Q4 24
$467.2M
$43.3M
Q3 24
$410.5M
$32.3M
Q2 24
$346.9M
$28.7M
Total Debt
HRMY
HRMY
MAX
MAX
Q1 26
$163.5M
Q4 25
$163.7M
$153.4M
Q3 25
$168.5M
$155.7M
Q2 25
$172.1M
$158.0M
Q1 25
$175.7M
$160.2M
Q4 24
$179.3M
$162.4M
Q3 24
$182.8M
$164.7M
Q2 24
$186.4M
$166.9M
Stockholders' Equity
HRMY
HRMY
MAX
MAX
Q1 26
Q4 25
$870.2M
$4.2M
Q3 25
$835.1M
$-29.8M
Q2 25
$773.1M
$-3.8M
Q1 25
$720.5M
$7.9M
Q4 24
$659.2M
$2.4M
Q3 24
$596.8M
$-8.4M
Q2 24
$538.6M
$-24.4M
Total Assets
HRMY
HRMY
MAX
MAX
Q1 26
$367.7M
Q4 25
$1.3B
$383.8M
Q3 25
$1.2B
$266.2M
Q2 25
$1.1B
$249.4M
Q1 25
$1.1B
$240.0M
Q4 24
$999.2M
$262.4M
Q3 24
$928.1M
$236.1M
Q2 24
$858.4M
$198.2M
Debt / Equity
HRMY
HRMY
MAX
MAX
Q1 26
Q4 25
0.19×
36.88×
Q3 25
0.20×
Q2 25
0.22×
Q1 25
0.24×
20.23×
Q4 24
0.27×
68.31×
Q3 24
0.31×
Q2 24
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HRMY
HRMY
MAX
MAX
Operating Cash FlowLast quarter
$126.2M
Free Cash FlowOCF − Capex
$126.0M
FCF MarginFCF / Revenue
51.7%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
5.61×
TTM Free Cash FlowTrailing 4 quarters
$347.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HRMY
HRMY
MAX
MAX
Q1 26
Q4 25
$126.2M
$-7.4M
Q3 25
$108.7M
$23.6M
Q2 25
$79.3M
$25.7M
Q1 25
$34.0M
$23.7M
Q4 24
$75.6M
$14.5M
Q3 24
$70.5M
$8.1M
Q2 24
$42.6M
$21.6M
Free Cash Flow
HRMY
HRMY
MAX
MAX
Q1 26
Q4 25
$126.0M
$-7.5M
Q3 25
$108.7M
$23.6M
Q2 25
$79.3M
$25.5M
Q1 25
$33.9M
$23.6M
Q4 24
$75.0M
$14.5M
Q3 24
$70.5M
$8.0M
Q2 24
$42.0M
$21.5M
FCF Margin
HRMY
HRMY
MAX
MAX
Q1 26
Q4 25
51.7%
-2.6%
Q3 25
45.4%
7.7%
Q2 25
39.6%
10.2%
Q1 25
18.3%
8.9%
Q4 24
37.3%
4.8%
Q3 24
37.9%
3.1%
Q2 24
24.3%
12.0%
Capex Intensity
HRMY
HRMY
MAX
MAX
Q1 26
Q4 25
0.0%
0.0%
Q3 25
0.0%
0.0%
Q2 25
0.0%
0.1%
Q1 25
0.1%
0.0%
Q4 24
0.3%
0.0%
Q3 24
0.0%
0.0%
Q2 24
0.4%
0.1%
Cash Conversion
HRMY
HRMY
MAX
MAX
Q1 26
Q4 25
5.61×
-0.24×
Q3 25
2.14×
1.58×
Q2 25
1.99×
Q1 25
0.75×
Q4 24
1.53×
3.13×
Q3 24
1.53×
0.85×
Q2 24
3.68×
5.97×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons